Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, July 6, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2016, to shareholders of record at the close of business…

Mesa Labs Acquires Additional Canadian Dental Sterilizer Testing Business

Lakewood, Colorado, July 5, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of certain assets and liabilities of HANSAmed Limited (“HANSAmed”) by the Company’s subsidiary, Mesa Canada, Inc. (“Mesa Canada”). HANSAmed was a distributor of the Company’s biological indicator (“BI”) products and mail-in testing services to…

Mesa Labs Reports Record Net Income and Revenues

Lakewood, Colorado, June 2, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record net income and revenues for both the quarter and the year ended March 31, 2016. Highlights for the quarter and year ended March 31, 2016 as compared to the same periods last year: Revenues increased…

Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, April 12, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2016, to shareholders of record at the close of business…

Mesa Labs Acquires Canadian Distribution Rights for its Biological Indicators Division

Lakewood, Colorado, April 6, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of certain assets and liabilities of Pulse Scientific, Inc. (“Pulse”) by the Company’s subsidiary, Mesa Canada, Inc. (“Mesa Canada”). Pulse was a distributor of the Company’s biological indicator (“BI”) products. The acquisition is expected…

Mesa Labs Acquires Additional European Distribution Rights for its Biological Indicators Division

Lakewood, Colorado, January 4, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of certain assets and liabilities of two of its European distributors by the Company’s subsidiary, Mesa France SAS (“Mesa France”), located near Lyon, France. These acquisitions involved CoaChrom Diagnostica GmbH of Austria and bioTRADING…